Artivion to Participate in Major Healthcare MedTech Conference
Artivion, Inc. (NYSE: AORT), an innovative company specializing in cardiac and vascular surgery solutions, is set to take part in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference. This virtual event is an excellent platform for Artivion to share its advances and ongoing commitment to improving patient care.
Virtual Fireside Chat Information
The company's virtual fireside chat is scheduled for 10:40 a.m. ET on March 18, 2025. During this session, Artivion will discuss its latest developments and innovations in addressing aortic diseases, a significant focus for the company. Individuals interested in participating will be able to access the live webcast on Artivion's official website, ensuring a wide audience can engage with the insights shared.
Artivion’s Commitment to Innovation
Artivion is committed to developing solutions that make a tangible difference in the lives of patients facing complex cardiac challenges. Their innovative products, including aortic stent grafts and surgical sealants, reflect a deep understanding of the needs of cardiac surgeons. This commitment is what drives Artivion to participate in prominent industry events like the MedTech Conference, allowing them to connect with peers and showcase their advancements.
About Artivion, Inc.
Headquartered in Atlanta, Georgia, Artivion, Inc. is renowned for its dedication to creating simple yet effective medical devices that aid cardiac and vascular surgeons. The company specializes in developing a range of products that are instrumental in treating aortic diseases. Their product line includes advanced surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion's products are distributed in over 100 countries, highlighting their global reach and impact in the healthcare sector.
Product Offerings
Artivion’s diverse product offerings emphasize their commitment to quality and effectiveness in medical procedures. The aortic stent grafts help facilitate smoother surgical processes, while On-X mechanical heart valves provide reliable alternatives for patients requiring heart valve replacements. Surgical sealants developed by Artivion also play a crucial role in enhancing recovery and minimizing complications during surgery.
Contact Information for Inquiries
For those interested in learning more or having queries regarding Artivion's offerings, they can reach out to the company directly. Lance A. Berry, the Executive Vice President and Chief Financial Officer, is available for inquiries, ensuring that stakeholders receive timely and relevant information concerning the company’s initiatives and products.
Artivion can be contacted through:
- Phone: 332-895-3222
- Email: Available via company communications
Stay tuned for more updates from Artivion as they continue to engage in enriching discussions surrounding the future of healthcare and innovations that improve surgical outcomes for patients worldwide.
Frequently Asked Questions
1. What is the purpose of Artivion's participation in the conference?
The conference provides a platform for Artivion to showcase its latest innovations and share insights into its developments in cardiac and vascular surgery solutions.
2. When will the virtual fireside chat take place?
The virtual fireside chat is scheduled for March 18, 2025, at 10:40 a.m. ET.
3. Where can I access the webcast of the fireside chat?
The webcast will be accessible through Artivion's official website on the Investors page.
4. What types of products does Artivion offer?
Artivion offers a range of products including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues.
5. How can I contact Artivion for more information?
Interested individuals can contact Artivion through their direct phone line or via company communications for further inquiries.
